195 related articles for article (PubMed ID: 6971636)
1. [Immunology and tumors. Effector cells].
Sebastiani M; Cosma AM; Ferri AM
Arch Sci Med (Torino); 1980; 137(2):277-88. PubMed ID: 6971636
[TBL] [Abstract][Full Text] [Related]
2. [Cytolytic activity of macrophages and T-lymphocytes in regard to tumor cells in the presence of normal tissue cells].
Lavrovskiĭ VA; Dobrunova EP
Eksp Onkol; 1990; 12(4):77-8. PubMed ID: 2379495
[No Abstract] [Full Text] [Related]
3. Host factors important in immune surveillance against tumours.
Ada GL
IARC Sci Publ; 1982; (39):223-39. PubMed ID: 6185418
[TBL] [Abstract][Full Text] [Related]
4. An introduction to tumour immunology.
James K
Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
[TBL] [Abstract][Full Text] [Related]
5. [Effect of chemotherapy on anticancer immune effector cells].
Saijo N
Gan To Kagaku Ryoho; 1983 Mar; 10(3):699-707. PubMed ID: 6410999
[TBL] [Abstract][Full Text] [Related]
6. Natural killer and other effector cells.
Stutman O; Lattime EC
Symp Fundam Cancer Res; 1986; 38():221-58. PubMed ID: 3489260
[No Abstract] [Full Text] [Related]
7. [Nonspecific natural cytotoxicity as an active participant in the ensemble of the means of immune defense].
Olinescu A
Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1982; 27(3):141-55. PubMed ID: 6984209
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
[TBL] [Abstract][Full Text] [Related]
9. [New insights into cytotoxic effector cells].
Rey J; Olive D; Sébahoun G; O'Callaghan T; Costello RT
Bull Cancer; 2005 Nov; 92(11):935-43. PubMed ID: 16316827
[TBL] [Abstract][Full Text] [Related]
10. Natural killer (NK) cells and their possible roles in resistance against disease.
Herberman RB
Clin Immunol Rev; 1981; 1(1):1-65. PubMed ID: 6219848
[No Abstract] [Full Text] [Related]
11. Natural cytotoxic cells against solid tumors in mice: a comparison with natural killer cells.
Stutman O; Lattime EC; Figarella EF
Fed Proc; 1981 Oct; 40(12):2699-704. PubMed ID: 7286250
[TBL] [Abstract][Full Text] [Related]
12. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
13. [Immunological and morphological properties of in vitro transformed fibroblasts. III. Recognition by macrophages and activated lymphocytes of mouse and rat cells of various degrees of tumorigenicity].
Lavrovskiĭ VA; Iurchenko IuA; Guvakova MA
Tsitologiia; 1987 May; 29(5):589-95. PubMed ID: 3617224
[TBL] [Abstract][Full Text] [Related]
14. [Antitumoral action of interferons and interleukins in combination with radiotherapy. Part I: immunologic basis].
Herskind C; Fleckenstein K; Lohr J; Li CY; Wenz F; Lohr F
Strahlenther Onkol; 2004 Apr; 180(4):187-93. PubMed ID: 15057428
[TBL] [Abstract][Full Text] [Related]
15. Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells.
Street SE; Hayakawa Y; Zhan Y; Lew AM; MacGregor D; Jamieson AM; Diefenbach A; Yagita H; Godfrey DI; Smyth MJ
J Exp Med; 2004 Mar; 199(6):879-84. PubMed ID: 15007091
[TBL] [Abstract][Full Text] [Related]
16. [Immunological and morphological properties of fibroblasts transformed in vitro. II. The change in the susceptibility of FC3H3 cells to lymphocytes--natural killers and macrophages during their selection for malignancy].
Lavrovskiĭ VA; Iurchenko IuA; Viksler VKh
Tsitologiia; 1984 Oct; 26(10):1181-5. PubMed ID: 6515718
[TBL] [Abstract][Full Text] [Related]
17. Exposing tumor cells to killer cell attack.
Watzl C; Long EO
Nat Med; 2000 Aug; 6(8):867-8. PubMed ID: 10932221
[No Abstract] [Full Text] [Related]
18. Natural killer and gammadelta T cells in haematological malignancies: enhancing the immune effectors.
Rey J; Veuillen C; Vey N; Bouabdallah R; Olive D
Trends Mol Med; 2009 Jun; 15(6):275-84. PubMed ID: 19487160
[TBL] [Abstract][Full Text] [Related]
19. Functions of natural killer cells.
Vivier E; Tomasello E; Baratin M; Walzer T; Ugolini S
Nat Immunol; 2008 May; 9(5):503-10. PubMed ID: 18425107
[TBL] [Abstract][Full Text] [Related]
20. Conjugate formation between effector and target as a function of cytotoxicity in antibody-dependent killing of AK-5 tumor.
Kausalya S; Pardhasaradhi BV; Manogaran PS; Khar A
Indian J Exp Biol; 1995 Mar; 33(3):161-4. PubMed ID: 7601484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
